We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A study found that around 4 months after vaccination, people who received the RSV vaccine had a 79% reduction in their risk of getting lower respiratory tract disease caused by RSV, compared with those who received placebo.
Weekly national influenza and COVID-19 report, COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.
Over a third of women giving birth got the new RSV vaccine in September, protecting newborns from severe illness.
UKHSA urges parents and carers to take these simple steps to ensure children make the healthiest start to the New Year.
The government has accepted advice from the Joint Committee on Vaccination and Immunisation (JCVI) for the spring 2025 COVID-19 vaccination programme.
Flu positivity jumps to 17.1% as vaccine take-up rates lag behind levels needed to protect the NHS and levels of norovirus highest in a decade for the time of year.
Latest UKHSA data indicates more flu is already circulating this winter compared to last year.
The purchase will boost the UK’s access to vaccines for a wider range of pathogens of pandemic potential.
The fight against meningococcal B continues.
RSV infections lead to 640,000 antibiotic prescriptions a year, new analysis from UKHSA, Imperial College London and Oxford Population Health has found.
The UK Health Security Agency (UKHSA) is reminding parents of the simple steps they can take to reduce the spread of stomach bugs and winter illnesses.
The latest weekly flu surveillance data published by UKHSA today shows flu case numbers are twice as high among school children, aged 5 to 14 years.
To better understand Mpox and its spread within the UK, VDEC developed an immunoassay to assess immune responses to Mpox infection and new vaccines.
The measles vaccination is part of the NHS Routine Childhood Immunisation Programme – with 1 dose offered at 1 year and a second dose at 3 years 4 months.
The UK Health Security Agency is encouraging students to make the healthiest start to their studies possible.
JCVI advises government on the COVID-19 vaccination programme for autumn 2024
A national respiratory syncytial virus (RSV) vaccine programme protecting infants and elderly people will save lives in the UK.
Antimicrobial resistance to Group B Streptococcus (GBS) antibiotics is growing. This puts newborns at risk. VDEC is supporting a new vaccine to cut antibiotic use
New data published today by the UK Health Security Agency (UKHSA) shows cases of whooping cough continue to increase with 2,591 cases confirmed in May.
This letter provides information on the respiratory syncytial virus (RSV) vaccination programmes from 1 September 2024.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).